1.Royal College of Obstetricians and Gynaecologists (RCOG). The Care of Women Requesting Induced Abortion. Evidence-based Clinical guideline No. 7. London: RCOG Press, 2011.
2.Royal College of Obstetricians and Gynaecologists (RCOG). Termination of Pregnancy for Fetal Abnormality in England, Scotland and Wales. Report of a Working Party. London: RCOG Press, 2010.
3.Kerns, J, Vanjani, R, Freedman, L, et al. Women’s decision making regarding choice of second trimester termination method for pregnancy complications. Int J Gynaecol Obst 2012; 116(3): 244–8.
4.Asplin, N, Wessel, H, Marions, L, et al. Pregnancy termination due to fetal anomaly: Women’s reactions, satisfaction and experiences of care. Midwifery 2014; 30(6): 620–7.
5.Royal College of Obstetricians and Gynaecologists (RCOG). Termination of Pregnancy for Fetal Abnormality in England, Wales and Scotland. Working Party Report. London: RCOG Press, 1996.
6.Wyldes, MP, Tonks, AM. Termination of pregnancy for fetal anomaly: a population-based study 1995 to 2004. BJOG 2007; 114: 639–42.
7.Draper, E, Alfirevic, Z, Stacey, F, et al. for the EPICure Study Group. An investigation into the reporting and management of late terminations of pregnancy (between 22+0 and 26+6 weeks of gestation) within NHS Hospitals in England in 2006: the EPICure preterm cohort study. BJOG 2012; 119: 710–5.
9.Graham, RH, Mason, K, Rankin, J, et al. The role of feticide in the context of late termination of pregnancy: a qualitative study of health professionals’ and parents’ views. Prenat Diagn 2009; 29: 875–81.
10.Royal College of Obstetricians and Gynaecologists (RCOG). Further issues relating to late abortion, fetal viability and registration of births and deaths. RCOG Statement. London: RCOG Press; 2001.
11.Pasquini, L, Pontello, V, Kumar, S. Intracardiac injection of potassium chloride as a method for feticide: experience from a single UK tertiary centre. BJOG 2008; 115: 528–31.
12.Bhide, A, Sairam, S, Hollis, B, et al. Comparison of feticide carried out by cordocentesis versus cardiac puncture. Ultrasound Obstet Gynecol 2002; 20: 230–2.
13.Molaei, M, Jones, HE, Weiselberg, T, et al. Effectiveness and safety of digoxin to induce fetal demise prior to second-trimester abortion. Contraception 2008; 77: 223–5.
14.Lyus, R, Robson, S, Parsons, J, et al. Second trimester abortion for fetal abnormality. BMJ 2013; 347: f4165.
16.Kelly, T, Suddes, J, Howel, D, et al. Comparing medical versus surgical termination of pregnancy at 13–20 weeks of gestation: a randomised controlled trial. BJOG 2010; 117: 1512–20.
17.Wildschut, H, Both, MI, Medema, S, et al. Medical methods for mid-trimester termination of pregnancy. Cochrane Database Syst Rev 2011; (1): CD005216.
18.World Health Organization (WHO). WHO Task Force on Post-ovulatory Methods of Fertility Regulation. Termination of pregnancy with reduced doses of mifepristone. BMJ 1993; 307: 532–7.
19.World Health Organization (WHO). WHO Task Force on Post-ovulatory Methods of Fertility Regulation. Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial. BJOG 2000; 107: 524–30.
21.World Health Organization. Safe Abortion: technical and policy guidance for health systems, 2nd edn, 2012.
22.Hamoda, H, Ashok, PW, Flett, GM, et al. Medical abortion at 64 to 91 days of gestation: a review of 483 consecutive cases. Am J Obstet Gynecol 2003; 188: 1315–9.
23.Ashok, PW, Kidd, A, Flett, GM, et al. A randomized comparison of medical abortion and surgical vacuum aspiration at 10–13 weeks gestation. Hum Reprod 2002; 17: 92–8.
24.Webster, D, Penney, GC, Templeton, A. A comparison of 600 and 200 mg mifepristone prior to second trimester abortion with the prostaglandin misoprostol. Br J Obstet Gynaecol 1996; 103: 706–9.
25.Bartley, J, Baird, DT. A randomised study of misoprostol and gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy. BJOG 2002; 109: 1290–4.
26.Gemzell-Danielsson, K, Lalitkumar, S. Second trimester medical abortion with mifepristone-misprostol and misoprostol alone: a review of methods and management. Reprod Health Matters 2008; 16(31): 162–72.
27.World Health Organization (WHO). WHO recommendations for Induction of Labour. Geneva: WHO, 2011.
28.Ashok, PW, Templeton, A, Wagaarachchi, PT, et al. Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases. Contraception 2004; 69(1): 51–8.
29.Davis, VJ. Induced abortion guidelines, Society of Obstetricians and Gynaecologists of Canada clinical practice guidelines No. 184. J Obstet Gynaecol Can 2008; 30(11): 1014–27.
30.Hammond, C. Recent advances in second-trimester abortion: an evidence-based review. Am J Obstet Gynecol 2009; 200(4): 347–56.
31.Berghella, V, Airoldi, J, O’Neill, AM, et al. Misoprostol for second trimester pregnancy termination in women with prior caesarean: a systematic review. BJOG 2009; 116(9): 1151–7.
32.Dodd, JM, Crowther, CA. Misoprostol versus cervagem for the induction of labour to terminate pregnancy in the second and third trimester: a systematic review. Eur J Obstet Gynecol Reprod Biol 2006; 125(1): 3–8.
33.Güleç, UK, Urunsak, IF, Eser, E, et al. Misoprostol for midtrimester termination of pregnancy in women with 1 or more prior cesarean deliveries. Int J of Gynecol Obstet 2013; 120(1): 85–87.
34.Fawzy, M, Abdel-Hady el, S. Midtrimester abortion using vaginal misoprostol for women with three or more prior cesarean deliveries. Int J Gynecol Obstet 2010; 110(1): 50–2.
35.Gemzell-Danielsson, K, Ostlund, E. Termination of second trimester pregnancy with mifepristone and gemeprost. The clinical experience of 197 consecutive cases. Acta Obstet Gynecol Scand 2000; 79(8): 702–6.
36.Jackson, E, Kapp, N. Pain control in first-trimester and second-trimester medical termination of pregnancy: a systematic review. Contraception 2011; 83: 116–26.
37.Fiala, C, Swahn, ML, Stephansson, O, et al. The effect of non-steroidal anti-inflammatory drugs on medical abortion with mifepristone and misoprostol at 13–22 weeks gestation. Hum Reprod 2005; 20: 3072–7.
38.Hamoda, H, Ashok, PW, Flett, GM, et al. Analgesia requirements and predictors of analgesia use for women undergoing medical abortion up to 22 weeks of gestation. BJOG 2004; 111(9): 996–1000.
39.Tuncalp, O, Gülmezoglu, AM, Souza, JP. Surgical procedures for evacuating incomplete miscarriage. Cochrane Database Syst Rev 2010; 9: CD001993.
40.Kulier, R, Cheng, L, Fekih, A, et al. Surgical methods for first trimester termination of pregnancy. Cochrane Database Syst Rev 2001; 4: CD002900.
41.Stubblefield, PG, Albrecht, BH, Koos, B, et al. A randomized study of 12 mm and 15.9 mm cannulas in midtrimester abortion by laminaria and vacuum curettage. Fertil Steril 1978; 29: 512–7.
42.Kapp, N, Lohr, PA, Ngo, TD, et al. Cervical preparation for first trimester surgical abortion. Cochrane Database Syst Rev 2010; 2: CD007207.
43.Newmann, SJ, Dalve-Endres, A, Diedrich, JT, et al. Cervical preparation for second trimester dilation and evacuation. Cochrane Database Syst Rev 2010; 8: CD007310.
44.Li, CF, Wong, CY, Chan, CP, et al. A study of co-treatment of nonsteroidal anti-inflammatory drugs (NSAIDs) with misoprostol for cervical priming before suction termination of first trimester pregnancy. Contraception 2003; 67: 101–5.
45.Niinimäki, M, Pouta, A, Bloigu, A, et al. Immediate complications after medical compared with surgical termination of pregnancy. Obstet Gynecol 2009; 114: 795–804.
46.Grimes, DA, Schulz, KF. Morbidity and mortality from second-trimester abortions. J Reprod Med 1985; 30: 505–14.
47.Ashok, PW, Kidd, A, Flett, GM, et al. A randomized comparison of medical abortion and surgical vacuum aspiration at 10–13 weeks gestation. Hum Reprod 2002; 17: 92–8.
48.Neilson, JP, Gyte, GM, Hickey, M, et al. Medical treatments for incomplete miscarriage (less than 24 weeks). Cochrane Database Syst Rev 2010; 1: CD007223.
49.Low, N, Mueller, M, Van Viet, HAAM, et al. Perioperative antibiotics to prevent infection after first-trimester abortion. Cochrane Database Syst Rev 2012; 3: CD005217.
50.Ho, CS, Bhatnagar, J, Cohen, AL, et al. Undiagnosed cases of fatal Clostridium-associated toxic shock in Californian women of childbearing age. Am J Obstet Gynecol 2009; 201: 459–7.
51.Kale, SG, Szigetvari, IA, Bartfai, GS. The frequency and management of uterine perforations during 1st-trimester abortions. Am J Obstet Gynecol 1989; 161: 406–8.
52.Rowland Hogue, CJ, Terry, MPH, Boardman, LA, et al. Answering questions about long-term outcomes. In: Paul, M, Lichtenberg, ES, Borgatta, L, et al., (eds). Management of Unintended and Abnormal Pregnancy: Comprehensive Abortion Care. Hoboken, NJ: Wiley-Blackwell, 2009: 252–63.